migalastat has been researched along with Innate Inflammatory Response in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| D'Alonzo, D; Dechecchi, MC; Esposito, A; Fenza, M; Gregorio, E; Guaragna, A; Lippi, G; Tamanini, A | 1 |
| Butters, T; Dwek, R; Frendeus, B; Platt, F; Svanborg, C; Svensson, M | 1 |
1 review(s) available for migalastat and Innate Inflammatory Response
| Article | Year |
|---|---|
Synthesis and Therapeutic Applications of Iminosugars in Cystic Fibrosis.
Topics: 1-Deoxynojirimycin; Anti-Inflammatory Agents; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Glycoside Hydrolases; Glycosyltransferases; Heterocyclic Compounds, 1-Ring; Humans; Imino Pyranoses; Inflammation; Molecular Structure; Mutation; Sequence Deletion; Tartrates | 2020 |
1 other study(ies) available for migalastat and Innate Inflammatory Response
| Article | Year |
|---|---|
Carbohydrate receptor depletion as an antimicrobial strategy for prevention of urinary tract infection.
Topics: 1-Deoxynojirimycin; Bacterial Adhesion; Escherichia coli; Escherichia coli Infections; Fimbriae, Bacterial; Glycolipids; Glycosphingolipids; Humans; Inflammation; Urinary Tract Infections | 2001 |